Hepatitis c Trials in Bradenton, United States
Conditions / Hepatitis c / Bradenton, United States
Hepatitis c is a medical condition with active clinical research programs worldwide.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01183169 | Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment | COMPLETED | PHASE2 |
| NCT01297270 | Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2) | COMPLETED | PHASE3 |
| NCT01497366 | Phase 3 Study of Sofosbuvir and Ribavirin | COMPLETED | PHASE3 |
| NCT01467505 | An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients | TERMINATED | PHASE2 |
| NCT01500772 | Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C | TERMINATED | PHASE3 |
| NCT01281423 | Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection | UNKNOWN_STATUS | PHASE2 |
| NCT01180790 | Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants | COMPLETED | PHASE2 |
| NCT03944447 | Outcomes Mandate National Integration With Cannabis as Medicine | UNKNOWN | PHASE2 |
| NCT02753699 | Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients | COMPLETED | PHASE3 |
| NCT01318694 | Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants | COMPLETED | PHASE3 |